KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Gross Margin Growth (3y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 531.00
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn -168.00
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 449.00
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn 134.00
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn -367.00
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 129.00
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn -1,698.00
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn -714.00
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 449.00
Dec 31, 2025 19.00
Sep 30, 2025 28.00
Jun 30, 2025 42.00
Mar 31, 2025 -6.00
Dec 31, 2024 -9.00
Sep 30, 2024 148.00
Jun 30, 2024 335.00
Mar 31, 2024 -87.00
Dec 31, 2023 -609.00
Sep 30, 2023 -742.00
Jun 30, 2023 502.00
Mar 31, 2023 -1,007.00
Dec 31, 2022 -453.00
Sep 30, 2022 -1,126.00
Jun 30, 2022 -656.00
Mar 31, 2022 -829.00
Dec 31, 2021 -467.00
Sep 30, 2021 -833.00
Jun 30, 2021 -904.00
Mar 31, 2021 -809.00
Dec 31, 2020 -433.00
Sep 30, 2020 -1,604.00
Jun 30, 2020 -1,358.00
Mar 31, 2020 219.00
Dec 31, 2019 -18.00
Sep 30, 2019 74.00
Jun 30, 2019 -26.00
Mar 31, 2019 134.00
Dec 31, 2018 -130.00
Sep 30, 2018 -265.00
Jun 30, 2018 83,271.00
Mar 31, 2018 -560.00
Dec 31, 2017 -895.00
Sep 30, 2017 -131.00
Jun 30, 2017 58.00
Mar 31, 2017 -61.00
Dec 31, 2016 222.00
Sep 30, 2016 6.00
Jun 30, 2016 69.00
Mar 31, 2016 366.00
Dec 31, 2015 125.00
Sep 30, 2015 286.00
Jun 30, 2015 -83,219.00
Mar 31, 2015 901.00